Sirtuins connect energy generation and metabolic stress to the cellular acetylome. Currently, only the mitochondrial sirtuins (SIRT3–5) and SIRT1 have been shown to direct mitochondrial function; however, Aims: NAD-dependent protein deacetylase sirtuin-2 (SIRT2), the primary cytoplasmic sirtuin, is not yet reported to associate with mitochondria.
Results:
This study revealed a novel physiological function of SIRT2: the regulation of mitochondrial function. First, the acetylation of several metabolic mitochondrial proteins was found to be altered in Sirt2-deficient mice, which was, subsequently, validated by immunoprecipitation experiments in which the acetylated mitochondrial proteins directly interacted with SIRT2. Moreover, immuno-gold electron microscopic images of mouse brains showed that SIRT2 associates with the inner mitochondrial membrane in central nervous system cells. The loss of Sirt2 increased oxidative stress, decreased adenosine triphosphate levels, and altered mitochondrial morphology at the cellular and tissue (i.e., brain) level. Furthermore, the autophagic/mitophagic processes were dysregulated in Sirt2-deficient neurons and mouse embryonic fibroblasts.
Innovation:
For the first time it is shown that SIRT2 directs mitochondrial metabolism.
Conclusion:
Together, these findings support that SIRT2 functions as a mitochondrial sirtuin, as well as a regulator of autophagy/mitophagy to maintain mitochondrial biology, thus facilitating cell survival. Antioxid. Redox Signal. 26, 849–863.
Get full access to this article
View all access options for this article.
References
1.
AquilanoK, VigilanzaP, BaldelliS, PaglieiB, RotilioG, and CirioloMR. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem, 285: 21590–21599, 2010.
2.
BalabanRS, NemotoS, and FinkelT. Mitochondria, oxidants, and aging. Cell, 120: 483–495, 2005.
3.
BeirowskiB, GustinJ, ArmourSM, YamamotoH, ViaderA, NorthBJ, MichanS, BalohRH, GoldenJP, SchmidtRE, SinclairDA, AuwerxJ, and MilbrandtJ. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc Natl Acad Sci U S A, 108: E952–E961, 2011.
4.
ChalkiadakiA and GuarenteL. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer, 15: 608–624, 2015.
5.
ChoudharyC, KumarC, GnadF, NielsenML, RehmanM, WaltherTC, OlsenJV, and MannM. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science, 325: 834–840, 2009.
6.
DonmezG and GuarenteL. Aging and disease: connections to sirtuins. Aging Cell, 9: 285–290, 2010.
7.
FinkelT, DengCX, and MostoslavskyR. Recent progress in the biology and physiology of sirtuins. Nature, 460: 587–591, 2009.
8.
FinleyLW, CarracedoA, LeeJ, SouzaA, EgiaA, ZhangJ, Teruya-FeldsteinJ, MoreiraPI, CardosoSM, ClishCB, PandolfiPP, and HaigisMC. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell, 19: 416–428, 2011.
9.
FinleyLW and HaigisMC. Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med, 18: 516–523, 2012.
10.
FrankS, GaumeB, Bergmann-LeitnerES, LeitnerWW, RobertEG, CatezF, SmithCL, and YouleRJ. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell, 1: 515–525, 2001.
11.
GiusD and SpitzDR. Redox signaling in cancer biology. Antioxid Redox Signal, 8: 1249–1252, 2006.
12.
GlozakMA, SenguptaN, ZhangX, and SetoE. Acetylation and deacetylation of non-histone proteins. Gene, 363: 15–23, 2005.
13.
GomesLC and ScorranoL. Mitochondrial morphology in mitophagy and macroautophagy. Biochim Biophys Acta, 1833: 205–212, 2013.
14.
GuarenteL. Calorie restriction and SIR2 genes—towards a mechanism. Mech Ageing Dev, 126: 923–928, 2005.
15.
GuarenteL. Sirtuins in aging and disease. Cold Spring Harb Symp Quant Biol, 72: 483–488, 2007.
16.
GuarenteL. Mitochondria—a nexus for aging, calorie restriction, and sirtuins?. Cell, 132: 171–176, 2008.
17.
GuarenteL. Aging research-where do we stand and where are we going?. Cell, 159: 15–19, 2014.
18.
GuarenteL. The many faces of sirtuins: sirtuins and the Warburg effect. Nat Med, 20: 24–25, 2014.
HaigisMC, DengCX, FinleyLW, KimHS, and GiusD. SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Res, 72: 2468–2472, 2012.
21.
HaigisMC and GuarenteLP. Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction. Genes Dev, 20: 2913–2921, 2006.
22.
HaigisMC and SinclairDA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol, 5: 253–295, 2010.
23.
HardyJ. Genetic analysis of pathways to Parkinson disease. Neuron, 68: 201–206, 2010.
24.
HeW, NewmanJC, WangMZ, HoL, and VerdinE. Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends Endocrinol Metab, 23: 467–476, 2012.
25.
HirscheyMD, ShimazuT, CapraJA, PollardKS, and VerdinE. SIRT1 and SIRT3 deacetylate homologous substrates: AceCS1,2 and HMGCS1,2. Aging (Albany NY), 3: 635–642, 2011.
26.
HoutkooperRH, PirinenE, and AuwerxJ. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol, 13: 225–238, 2012.
27.
JiangW, WangS, XiaoM, LinY, ZhouL, LeiQ, XiongY, GuanKL, and ZhaoS. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol Cell, 43: 33–44, 2011.
28.
KaeberleinM, McVeyM, and GuarenteL. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev, 13: 2570–2580, 1999.
29.
KimHS, PatelK, Muldoon-JacobsK, BishtKS, Aykin-BurnsN, PenningtonJD, van der MeerR, NguyenP, SavageJ, OwensKM, VassilopoulosA, OzdenO, ParkSH, SinghKK, AbdulkadirSA, SpitzDR, DengCX, and GiusD. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell, 17: 41–52, 2010.
30.
KimHS, VassilopoulosA, WangRH, LahusenT, XiaoZ, XuX, LiC, VeenstraTD, LiB, YuH, JiJ, WangXW, ParkSH, ChaYI, GiusD, and DengCX. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell, 20: 487–499, 2011.
31.
KimSC, SprungR, ChenY, XuY, BallH, PeiJ, ChengT, KhoY, XiaoH, XiaoL, GrishinNV, WhiteM, YangXJ, and ZhaoY. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell, 23: 607–618, 2006.
32.
LantierL, WilliamsAS, WilliamsIM, YangKK, BracyDP, GoelzerM, JamesFD, GiusD, and WassermanDH. SIRT3 is crucial for maintaining skeletal muscle insulin action and protects against severe insulin resistance in high-fat-fed mice. Diabetes, 64: 3081–3092, 2015.
33.
MaxwellMM, TomkinsonEM, NoblesJ, WizemanJW, AmoreAM, QuintiL, ChopraV, HerschSM, and KazantsevAG. The sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet, 20: 3986–3996, 2011.
34.
NakagawaT and GuarenteL. SnapShot: sirtuins, NAD, and aging. Cell Metab, 20: 192–192e1, 2014.
35.
NarendraD, WalkerJE, and YouleR. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. Cold Spring Harb Perspect Biol, 4: pii: a0113382012.
36.
NorthBJ, MarshallBL, BorraMT, DenuJM, and VerdinE. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell, 11: 437–444, 2003.
37.
OzdenO, ParkSH, WagnerBA, Yong SongH, ZhuY, VassilopoulosA, JungB, BuettnerGR, and GiusD. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free Radic Biol Med, 76: 163–172, 2014.
38.
ParisiadouL, YuJ, SgobioC, XieC, LiuG, SunL, GuXL, LinX, CrowleyNA, LovingerDM, and CaiH. LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nat Neurosci, 17: 367–376, 2014.
PillaiVB, SamantS, SundaresanNR, RaghuramanH, KimG, BonnerMY, ArbiserJL, WalkerDI, JonesDP, GiusD, and GuptaMP. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3. Nat Commun, 6: 6656, 2015.
41.
StoyanovskyDA, TyurinaYY, TyurinVA, AnandD, MandaviaDN, GiusD, IvanovaJ, PittB, BilliarTR, and KaganVE. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc, 127: 15815–15823, 2005.
42.
TannyJC, DowdGJ, HuangJ, HilzH, and MoazedD. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell, 99: 735–745, 1999.
43.
TwigG and ShirihaiOS. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal, 14: 1939–1951, 2011.
44.
WhitworthAJ and PallanckLJ. The PINK1/Parkin pathway: a mitochondrial quality control system?. J Bioenerg Biomembr, 41: 499–503, 2009.
45.
YuJ and AuwerxJ. The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci, 1173Suppl 1: E10–E19, 2009.
46.
ZhaoY, YangJ, LiaoW, LiuX, ZhangH, WangS, WangD, FengJ, YuL, and ZhuWG. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol, 12: 665–675, 2010.
47.
ZhuY, YanY, PrincipeDR, ZouX, VassilopoulosA, and GiusD. SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis. Cancer Metab, 2: 15, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
